PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16929507-0	2007	Effects of tripterine on mRNA expression of TGF-beta1 and collagen IV expression in BW F1 mice.	celastrol	11-21	transforming growth factor, beta 1	Mus musculus	44-53	
25076938-15	2014	Furthermore, celastrol suppressed TGF-beta1 induced EMT in thyroid cancer cells and may have therapeutic potential.	celastrol	13-22	transforming growth factor, beta 1	Mus musculus	34-43	
16929507-6	2007	Tripterine decreased urine protein excretion and the level of serum anti-dsDNA antibodies and also suppressed the expression of collagen type IV and TGF-beta1 mRNA in the murine kidney tissue.	celastrol	0-10	transforming growth factor, beta 1	Mus musculus	149-158	
12133425-4	2002	RESULTS: (1) Tripterine suppressed the development of proteinuria, decreased the level of serum anti-dsDNA antibodies, reduced the expressions of collagen type IV, fibronectin, TIMP-1, TIMP-2, TGF-beta(1) and improved the expressions of MMP-1, -2 in the murine kidney.	celastrol	13-23	transforming growth factor, beta 1	Mus musculus	193-204	
30798158-7	2019	RESULTS: C57BL/6 mice treated with CLT from 1 day post infection showed decreased disease, IL-1beta, TNF-alpha, IL-10, TGF-beta, MIP-2 and LOX-1 levels.	celastrol	35-38	transforming growth factor, beta 1	Mus musculus	119-127	
29789558-9	2018	Moreover, UUO- or TGF-beta1-induced activation of the pro-fibrotic factor SMAD family member 3 (Smad3) was markedly inhibited by celastrol.	celastrol	129-138	transforming growth factor, beta 1	Mus musculus	18-27	
27160852-15	2016	Celastrol attenuated miR-21 up-regulation by TGF-beta1 and decreased elevated p-ERK/ERK levels in CFs transfected with miR-21.	celastrol	0-9	transforming growth factor, beta 1	Mus musculus	45-54	
23637966-10	2013	Celastrol treatment significantly lowered mesangial expansion and suppressed type IV collagen, PAI-1 and TGFbeta1 expressions in renal tissues.	celastrol	0-9	transforming growth factor, beta 1	Mus musculus	105-113